David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Emerson Electric
EMR
|
+$546M |
| 2 |
Amazon
AMZN
|
+$515M |
| 3 |
Tesla
TSLA
|
+$389M |
| 4 |
Netflix
NFLX
|
+$322M |
| 5 |
Adobe
ADBE
|
+$305M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$836M |
| 2 |
CELG
Celgene Corp
CELG
|
+$460M |
| 3 |
NVIDIA
NVDA
|
+$429M |
| 4 |
ConocoPhillips
COP
|
+$311M |
| 5 |
Biogen
BIIB
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.8% |
| 2 | Consumer Discretionary | 11.76% |
| 3 | Healthcare | 10.16% |
| 4 | Financials | 7.89% |
| 5 | Industrials | 6.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Varonis Systems
VRNS
$4.69B
| $13.6M | 0.02% |
523,944
-76,035
| -13% | -$1.81M |
|
1002
PUT
Dell
DELL
$292B
| $13.6M | 0.02% |
520,872
+205,192
| +65% | +$5.34M |
|
1003
BHP
BHP
$251B
| $13.6M | 0.02% |
277,727
-107,975
| -28% | -$4.9M |
|
1004
CAE Inc
CAE
$8.05B
| $13.5M | 0.02% |
508,869
+266,900
| +110% | +$6.87M |
|
1005
Stantec
STN
$8.26B
| $13.5M | 0.02% |
476,500
+394,700
| +483% | +$9.76M |
|
1006
First Bancorp
FBP
$4.27B
| $13.4M | 0.02% |
1,269,411
-81,132
| -6% | -$847K |
|
1007
PUT
Expedia Group
EXPE
$40.6B
| $13.4M | 0.02% |
124,300
+82,000
| +194% | +$9.62M |
|
|
WCC
1008
WESCO International
WCC
$16.5B
| $13.4M | 0.02% |
226,058
-151,997
| -40% | -$7.93M |
|
1009
Ultragenyx Pharmaceutical
RARE
$2.61B
| $13.4M | 0.02% |
314,168
+125,785
| +67% | +$5.19M |
|
1010
Danaher
DHR
$152B
| $13.4M | 0.02% |
98,467
-223,212
| -69% | -$28.2M |
|
1011
Bristol-Myers Squibb
BMY
$139B
| $13.3M | 0.02% |
207,960
-809,258
| -80% | -$46.3M |
|
1012
QuidelOrtho
QDEL
$1.03B
| $13.3M | 0.02% |
177,286
-11,555
| -6% | -$746K |
|
|
QTS
1013
DELISTED
QTS REALTY TRUST, INC.
QTS
| $13.3M | 0.02% |
245,082
+22,661
| +10% | +$1.19M |
|
1014
CALL
Western Digital
WDC
$163B
| $13.2M | 0.02% |
275,052
-3,969
| -1% | -$166K |
|
1015
CALL
Cracker Barrel
CBRL
$1.3B
| $13.2M | 0.02% |
85,600
+15,000
| +21% | +$2.36M |
|
|
1016
CALL
Biogen
BIIB
$32.6B
| $13.1M | 0.02% |
44,300
-40,000
| -47% | -$11.1M |
|
|
1017
Western Digital
WDC
$163B
| $13.1M | 0.02% |
272,885
+83,842
| +44% | +$3.5M |
|
1018
CALL
Cigna
CI
$73.8B
| $13.1M | 0.01% |
63,924
+40,000
| +167% | +$7.33M |
|
|
IMGN
1019
DELISTED
Immunogen Inc
IMGN
| $13M | 0.01% |
2,553,910
+1,263,448
| +98% | +$4.29M |
|
|
ATSG
1020
DELISTED
Air Transport Services Group
ATSG
| $12.9M | 0.01% |
551,704
-56,940
| -9% | -$1.28M |
|
1021
PUT
Viatris
VTRS
$19.2B
| $12.9M | 0.01% |
642,200
-4,200
| -0.6% | -$78.2K |
|
1022
Leidos
LDOS
$16.9B
| $12.9M | 0.01% |
131,690
-154,732
| -54% | -$13.6M |
|
1023
CALL
MongoDB
MDB
$32.6B
| $12.9M | 0.01% |
97,900
+1,700
| +2% | +$223K |
|
1024
CALL
Constellation Brands
STZ
$23.1B
| $12.9M | 0.01% |
67,800
-11,800
| -15% | -$2.23M |
|
1025
PUT
PVH
PVH
$3.44B
| $12.8M | 0.01% |
121,300
| – | – |
|
Similar funds
David Shaw's Q4 2019 Portfolio in Review
As of Q4 2019, David Shaw held 4,337 positions worth $87.5B, up 7.7% from $81.2B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
David Shaw's Q4 2019 filing shows 572 new, 1,477 increased, 1,498 reduced and 412 closed positions. Its largest new stake was Tesla: 17,953,230 shares worth $501M. The largest sale was Alibaba, an estimated $836M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- David Shaw's largest Q4 2019 buy was Tesla: 17,953,230 shares worth $501M.
- David Shaw added most to Emerson Electric in Q4 2019, an estimated $546M increase.
- David Shaw's biggest Q4 2019 reduction was Alibaba, cutting an estimated $836M.
- David Shaw fully exited Celgene Corp in Q4 2019, selling an estimated $460M.
- David Shaw's ten largest holdings make up 10% of its $87.5B portfolio in Q4 2019.
- David Shaw opened 572 new positions and closed 412 in Q4 2019.
- David Shaw's portfolio value rose 7.7% quarter-over-quarter to $87.5B.
Based on D.E. Shaw & Co's 13F filing for Q4 2019, filed 14 Feb 2020.